Ultra Biotecs Limited - Abbreviated accounts 16.3

Ultra Biotecs Limited - Abbreviated accounts 16.3


07557627 1.4.15 31.3.16 31.3.16 Company accounts Private Limited Company FY true false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure075576272015-03-31075576272016-03-31075576272015-04-012016-03-31075576272014-03-31075576272014-04-012015-03-31075576272015-03-3107557627ns12:England2015-04-012016-03-3107557627ns14:PoundSterling2015-04-012016-03-3107557627ns7:Director12015-04-012016-03-3107557627ns7:OrdinaryShareClass12015-04-012016-03-3107557627ns7:Director22015-04-012016-03-3107557627ns7:Director32015-04-012016-03-3107557627ns7:Director42015-04-012016-03-3107557627ns7:RegisteredOffice2015-04-012016-03-3107557627ns7:EntityAccountantsOrAuditors2015-04-012016-03-3107557627ns5:PatentsConcessionsLicencesTradeMarksSimilar2015-04-012016-03-3107557627ns7:OrdinaryShareClass12016-03-3107557627ns7:OrdinaryShareClass12015-03-3107557627ns7:Director12015-03-3107557627ns7:Director12014-03-3107557627ns7:Director12014-04-012015-03-3107557627ns7:Director12016-03-3107557627ns7:Director12015-03-31
REGISTERED NUMBER: 07557627 (England and Wales)















Abbreviated Unaudited Accounts For The Year Ended 31 March 2016

for

Ultra Biotecs Limited

Ultra Biotecs Limited (Registered number: 07557627)

Contents of the Abbreviated Accounts
For The Year Ended 31 March 2016










Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 3

Ultra Biotecs Limited

Company Information
For The Year Ended 31 March 2016







DIRECTORS: Mr M Snowball
Mr S M Gordon
Mr P E Barr
Mr D Jones





REGISTERED OFFICE: 7 Billing Road
Northampton
Northamptonshire
NN1 5AN





REGISTERED NUMBER: 07557627 (England and Wales)





ACCOUNTANTS: Cochran, Harris & Clarke Ltd
7 Billing Road
Northampton
Northamptonshire
NN1 5AN

Ultra Biotecs Limited (Registered number: 07557627)

Abbreviated Balance Sheet
31 March 2016

2016 2015
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 2 5,373 13,693

CURRENT ASSETS
Debtors 58,043 35,549
Cash at bank 50,738 37,095
108,781 72,644
CREDITORS
Amounts falling due within one year 180,872 86,920
NET CURRENT LIABILITIES (72,091 ) (14,276 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(66,718

)

(583

)

CAPITAL AND RESERVES
Called up share capital 3 11,320 11,320
Share premium 249,680 249,680
Profit and loss account (327,718 ) (261,583 )
SHAREHOLDERS' FUNDS (66,718 ) (583 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2016.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2016 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end
of each financial year and of its profit or loss for each financial year in accordance with the requirements of
Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to
financial statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 30 November 2016 and were signed on its behalf
by:





Mr M Snowball - Director


Ultra Biotecs Limited (Registered number: 07557627)

Notes to the Abbreviated Accounts
For The Year Ended 31 March 2016


1. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared on a going concern basis. Since the year end the company has
issued a further 3,150 shares raising £502,365 which eliminates the shortfall in shareholders' funds.

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective January 2015).

Intangible assets
Patents purchased by the company are amortised individually over their anticipated economic life. The
anticipated economic life of the existing purchased patents is five years.

Applications for patents resulting from research and development expenditure is written off unless the patent has
a readily ascertainable market value in accordance with accounting standard FRS10.

Deferred tax
Deferred tax is recognised in respect of all material timing differences that have originated but not reversed at
the balance sheet date .Deferred tax assets arising from trading losses will not be recognised until future trading
profits are more readily ascertainable.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


Hire purchase and leasing commitments
Rentals paid under operating leases are charged to the profit and loss account on a straight line basis over the
period of the lease.

2. INTANGIBLE FIXED ASSETS
Total
£   
COST
At 1 April 2015
and 31 March 2016 41,600
AMORTISATION
At 1 April 2015 27,907
Amortisation for year 8,320
At 31 March 2016 36,227
NET BOOK VALUE

At 31 March 2016 5,373
At 31 March 2015 13,693

3. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2016 2015
value: £    £   
11,320 Ordinary £1 11,320 11,320

Ultra Biotecs Limited (Registered number: 07557627)

Notes to the Abbreviated Accounts - continued
For The Year Ended 31 March 2016


4. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2016 and
31 March 2015:

2016 2015
£    £   
Mr M Snowball
Balance outstanding at start of year - 3,980
Amounts advanced 3,925 -
Amounts repaid - (3,980 )
Balance outstanding at end of year 3,925 -

The loan is interest free with no fixed date of repayment